Rare McArdle disease locus polymorphic site on 11q13 contains CpG sequence

Area of Science:

• Genetics
• Molecular Biology
• Biochemistry

Background:

• McArdle disease, caused by myophosphorylase deficiency, requires genetic analysis for diagnosis and risk assessment.
• Identifying DNA polymorphisms within the myophosphorylase gene is crucial for developing informative genetic markers.

Purpose of the Study:

• To identify and characterize DNA polymorphisms in the McArdle disease (myophosphorylase) gene region.
• To compare polymorphism frequency with the homologous liver phosphorylase gene region.

Main Methods:

• Screening of the myophosphorylase gene region using DNA probes and enzyme digestion (MspI).
• Detection of insertion/deletion polymorphisms.
• Fluorescence in situ hybridization (FISH) for gene localization.

Main Results:

• Only one MspI polymorphism was identified in the McArdle disease gene region after extensive screening.
• An additional insertion/deletion polymorphism was found 3' to the gene locus.
• These polymorphisms are informative in 75% of at-risk patients.
• In contrast, six polymorphic sites were found in the homologous liver phosphorylase gene region.
• The identified MspI site contains a CpG sequence, suggesting increased mutability in regions with rare polymorphisms.
• The myophosphorylase gene was localized to chromosome 11q13 via FISH.

Conclusions:

• The McArdle disease gene region exhibits a low frequency of detectable DNA polymorphisms.
• The identified polymorphisms provide valuable tools for genetic counseling and carrier testing in McArdle disease.
• The study highlights a potential correlation between CpG sequences and polymorphism occurrence.
• Gene localization refines the physical and genetic mapping of the myophosphorylase gene.